The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|August 2, 2022
- Pharmaceutical Technology, August 2022
- Volume 46
- Issue 8
Accurate Level Switches
Author(s)Pharmaceutical Technology Editors
The Dynatrol G Series Level Switches are designed to accurately measure light or heavier bulk solids for problem applications.
The Dynatrol G Series Level Switches are intended for special problem applications involving very light or fluffy products or for heavier bulks solids that pack or bridge easily. Designed for accuracy on high, intermediate, or low-point level detection, the switches are built to work in dusty environments, while specialized units can be used in temperatures exceeding 300°F.
The Type GJ switch is designed for pharmaceutical powders, powder materials for coating beads and tablets, fillers, and other substances that vary widely in bulk density or particle size. The Type GS and GSS switches are also intended for fine powders while working with beads as light as polystyrene, for example, as well.
Articles in this issue
about 4 years ago
What Goes Wrong When API Quality is Compromised?about 4 years ago
Mitigating the Risk from Excipient Variabilityabout 4 years ago
Adapting to Solubility/Bioavailability Challengesabout 4 years ago
Progress in the Development of CAR NK-Cell Therapiesabout 4 years ago
Vaccine Administration: The Growing Role of Prefilled Syringesabout 4 years ago
Inspecting Finished Products with Precisionabout 4 years ago
An Integrated Approach to the Data Lifecycle in BioPharmaabout 4 years ago
Detecting Apparent Total Nitrosamine Content in Pharmaceutical DrugsRelated to this article
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Ravi Kiran Kaja, PhD, USP, explains what harmonization of extractables and leachables standards looks like in practice.